| scholarly article | Q13442814 |
| P50 | author | Marie-Laure Joly-Guillou | Q3292024 |
| P2093 | author name string | M Wolff | |
| C Carbon | |||
| R Farinotti | |||
| P2860 | cites work | Method of reliable determination of minimal lethal antibiotic concentrations | Q30451398 |
| Importance of penicillinase production for activity of penicillin alone or in combination with sulbactam in experimental endocarditis due to methicillin-resistant Staphylococcus aureus | Q35124432 | ||
| Efficacies of cefotaxime and ceftriaxone in a mouse model of pneumonia induced by two penicillin- and cephalosporin-resistant strains of Streptococcus pneumoniae | Q35130268 | ||
| Use of a new mouse model of Acinetobacter baumannii pneumonia to evaluate the postantibiotic effect of imipenem | Q35132306 | ||
| Penetration of ampicillin and sulbactam in the lower airways during respiratory infections | Q35257324 | ||
| Therapy of experimental murine brucellosis with streptomycin, co-trimoxazole, ciprofloxacin, ofloxacin, pefloxacin, doxycycline, and rifampin | Q35835303 | ||
| Therapy of Rhodococcus equi disseminated infections in nude mice | Q35862691 | ||
| Clinical and molecular epidemiology of acinetobacter infections sensitive only to polymyxin B and sulbactam | Q39391281 | ||
| Effect of sulbactam on infections caused by imipenem-resistant Acinetobacter calcoaceticus biotype anitratus | Q39411514 | ||
| Characterization of a hospital outbreak of imipenem-resistant Acinetobacter baumannii by phenotypic and genotypic typing methods | Q40180863 | ||
| Bactericidal effects of ticarcillin-clavulanic acid against beta-lactamase-producing bacteria in vivo | Q40283560 | ||
| Diastereomeric beta-lactam antibiotics. Analytical methods, isomerization and stereoselective pharmacokinetics | Q40507983 | ||
| Pharmacokinetic/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men. | Q41696128 | ||
| Community-acquired Acinetobacter pneumonia in the Northern Territory of Australia | Q43736106 | ||
| Drug therapy. Clinical Pharmacokinetics (first of two parts). | Q52867382 | ||
| Bactericidal in-vitro activity of beta-lactams and beta-lactamase inhibitors, alone or associated, against clinical strains of Acinetobacter baumannii: effect of combination with aminoglycosides. | Q54160718 | ||
| In-vitro and in-vivo activities of sulbactam and YTR830H against Acinetobacter calcoaceticus. | Q54313409 | ||
| Efficacy of sulbactam alone and in combination with ampicillin in nosocomial infections caused by multiresistant Acinetobacter baumannii | Q59245528 | ||
| Automated high-performance liquid chromatographic method for the determination of rifampicin in plasma | Q68226155 | ||
| Ticarcillin/clavulanic acid pharmacokinetics in children and young adults with cystic fibrosis | Q70113968 | ||
| A sensitive assay for clavulanic acid and sulbactam in biological fluids by high-performance liquid chromatography and precolumn derivatization | Q70254288 | ||
| Mortality due to ventilator-associated pneumonia or colonization with Pseudomonas or Acinetobacter species: assessment by quantitative culture of samples obtained by a protected specimen brush | Q71703071 | ||
| In-vitro and in-vivo activities of antimicrobial agents against Acinetobacter calcoaceticus | Q93575633 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | rifampicin | Q422652 |
| Acinetobacter baumannii | Q3241189 | ||
| P304 | page(s) | 1406-1411 | |
| P577 | publication date | 1999-06-01 | |
| P1433 | published in | Antimicrobial Agents and Chemotherapy | Q578004 |
| P1476 | title | In vivo efficacies of combinations of beta-lactams, beta-lactamase inhibitors, and rifampin against Acinetobacter baumannii in a mouse pneumonia model | |
| P478 | volume | 43 |
| Q34795807 | Acinetobacter baumannii: emergence of a successful pathogen |
| Q35314755 | Antimicrobial activity of the imipenem/rifampicin combination against clinical isolates of Acinetobacter baumannii grown in planktonic and biofilm cultures |
| Q24792473 | Comparison in a rat thigh abscess model of imipenem, meropenem and cefoperazone-sulbactam against Acinetobacter baumannii strains in terms of bactericidal efficacy and resistance selection |
| Q35895209 | Contribution of Acinetobacter-derived cephalosporinase-30 to sulbactam resistance in Acinetobacter baumannii |
| Q35205195 | Drug concentrations in the serum and cerebrospinal fluid of patients treated with cefoperazone/sulbactam after craniotomy |
| Q55347292 | Efficacy of Colistin and Its Combination With Rifampin in Vitro and in Experimental Models of Infection Caused by Carbapenemase-Producing Clinical Isolates of Klebsiella pneumoniae. |
| Q34109543 | Efficacy of colistin versus beta-lactams, aminoglycosides, and rifampin as monotherapy in a mouse model of pneumonia caused by multiresistant Acinetobacter baumannii |
| Q33676191 | Efficacy of rifampin and its combinations with imipenem, sulbactam, and colistin in experimental models of infection caused by imipenem-resistant Acinetobacter baumannii |
| Q83450247 | Efficacy of rifampin, in monotherapy and in combinations, in an experimental murine pneumonia model caused by panresistant Acinetobacter baumannii strains |
| Q43150667 | Efficacy of tigecycline vs. imipenem in the treatment of experimental Acinetobacter baumannii murine pneumonia. |
| Q33970252 | Emergence and rapid spread of carbapenem resistance during a large and sustained hospital outbreak of multiresistant Acinetobacter baumannii. |
| Q36095081 | Global challenge of multidrug-resistant Acinetobacter baumannii |
| Q37733474 | In vitro activities of the beta-lactamase inhibitors clavulanic acid, sulbactam, and tazobactam alone or in combination with beta-lactams against epidemiologically characterized multidrug-resistant Acinetobacter baumannii strains |
| Q37392820 | In vitro activity and in vivo efficacy of clavulanic acid against Acinetobacter baumannii. |
| Q39677063 | In vitro double and triple synergistic activities of Polymyxin B, imipenem, and rifampin against multidrug-resistant Acinetobacter baumannii |
| Q35139329 | Innate immune responses to systemic Acinetobacter baumannii infection in mice: neutrophils, but not interleukin-17, mediate host resistance |
| Q90402314 | Multidrug-resistant Acinetobacter baumannii strains with NDM-1: Molecular characterization and in vitro efficacy of meropenem-based combinations |
| Q36366778 | Nosocomial pneumonia : rationalizing the approach to empirical therapy |
| Q44615456 | Tetracyclines for treating multidrug-resistant Acinetobacter baumannii ventilator-associated pneumonia |
| Q87044330 | The increasing role of Acinetobacter species as nosocomial pathogens |
| Q37058001 | Treatment options for multidrug-resistant Acinetobacter species |
Search more.